documents: FDA-1975-N-0336-0035
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0336-0035 | FDA | FDA-1975-N-0336 | Letter from Valeant Pharmaceuticals North America LLC to FDA/CDER | Other | Letter(s) | 2012-10-02T04:00:00Z | 2012 | 10 | 2012-10-02T04:00:00Z | 2017-12-06T15:35:36Z | 0 | 0 | 09000064810f8657 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref